182 results on '"Goltz, Diane"'
Search Results
2. Lebersinusoide: Pathologie endothelialer Befunde
3. Autoimmune Lebererkrankungen
4. Loss of the LIM-only protein Fhl2 impairs inflammatory reaction and scar formation after cardiac ischemia leading to better hemodynamic performance
5. CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia
6. Histopathologische Klassifikation der Tumoren der Ampulla Vateri
7. Pathology of hepatocellular carcinoma and tumour bearing liver tissue in association with hTERT promotor mutation
8. Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck
9. α1-Antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease
10. Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl4 Exposure in Mice
11. Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer
12. Left ventricular obstruction with restrictive inter-atrial communication leads to retardation in fetal lung maturation
13. What Do Policy Makers Think of Educational Research & Evaluation? "Or Do They"?
14. Spindle cell rhabdomyosarcoma of the prostate
15. Modulation of the transient outward K+ current by inhibition of endothelin-A receptors in normal and hypertrophied rat hearts
16. Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using Fibroblast Growth Factor Receptor Inhibitors
17. Activating PDGFRA mutations in inflammatory fibroid polyps occur in exons 12, 14 and 18 and are associated with tumour localization
18. Acute Liver Injury after CCl4 Administration Is Independent of Smad7 Expression in Myeloid Cells
19. Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice
20. Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging
21. Getting the Buck to Stop Here: A Guide to Federal Resources for Special Needs.
22. CTLA4 methylation predicts response to anti–PD-1 and anti–CTLA-4 immunotherapy in melanoma patients
23. Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5′-nucleotidase, ecto,NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients
24. PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations
25. SCEC-MR News and Views
26. Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma
27. PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients
28. PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma
29. CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia
30. PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients
31. PD-L1promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
32. Die klinische Untersuchung – ein Auslaufmodell?
33. PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma
34. PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy
35. SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas
36. Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
37. CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients
38. Current Proceedings in the Molecular Dissection of Hepatocellular Adenomas: Review and Hands-on Guide for Diagnosis
39. Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer
40. Analysis of Tissue and Serum MicroRNA Expression in Patients with Upper Urinary Tract Urothelial Cancer
41. ATZ11 Recognizes Not Only Z-α1-Antitrypsin-Polymers and Complexed Forms of Non-Z-α1-Antitrypsin but Also the von Willebrand Factor
42. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion
43. Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.
44. Abstract 1698: ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer - A comparative study of two monoclonal antibodies
45. Abstract A30: ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer a comparative study of two monoclonal antibodies.
46. Abstract A64: ASPORIN expression is associated with prostate cancer progression and bone metastasis
47. Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis
48. Molecular and functional remodeling of Ito by angiotensin II in the mouse left ventricle
49. Common signatures for gene expression in postnatal patients with patent arterial ducts and stented arteries
50. Combined Pulmonary and Aortic Valve Stenosis – Prenatal Diagnosis and Postnatal Interventional Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.